These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serological analysis of patients treated with a new surgical hemostat containing bovine proteins and autologous plasma. Nelson PA; Powers JN; Estridge TD; Elder EA; Alea AD; Sidhu PK; Sehl LC; DeLustro FA J Biomed Mater Res; 2001; 58(6):710-9. PubMed ID: 11745525 [TBL] [Abstract][Full Text] [Related]
4. Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery. Flaherty MJ; Henderson R; Wener MH Ann Intern Med; 1989 Oct; 111(8):631-4. PubMed ID: 2802417 [TBL] [Abstract][Full Text] [Related]
5. Immune responses associated with perioperative exposure and reexposure to topical bovine thrombin do not impair hemostasis. Paterson CA; Pixton GC; Proskin HM; Massaro JM; Morasch M; Cronstein B; Fareed J; Ofosu FA Clin Appl Thromb Hemost; 2011; 17(6):620-32. PubMed ID: 21596694 [TBL] [Abstract][Full Text] [Related]
6. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ortel TL; Mercer MC; Thames EH; Moore KD; Lawson JH Ann Surg; 2001 Jan; 233(1):88-96. PubMed ID: 11141230 [TBL] [Abstract][Full Text] [Related]
7. Formation of heterophile antibodies by human tonsilar lymphocytes. II. In vitro stimulation with allogeneic cells. Mori T; Kano K; Merrick JM; Milgrom F Cell Immunol; 1981 Mar; 58(2):246-56. PubMed ID: 6971169 [No Abstract] [Full Text] [Related]
8. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function. Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. Rapaport SI; Zivelin A; Minow RA; Hunter CS; Donnelly K Am J Clin Pathol; 1992 Jan; 97(1):84-91. PubMed ID: 1728869 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus infection and heterophile antibody production. Schumacher HR; Austin RM; Stass SA Lancet; 1979 Jun; 1(8128):1247. PubMed ID: 87716 [No Abstract] [Full Text] [Related]
12. Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin. Neschis DG; Heyman MR; Cheanvechai V; Benjamin ME; Flinn WR J Vasc Surg; 2002 Feb; 35(2):400-2. PubMed ID: 11854743 [TBL] [Abstract][Full Text] [Related]